Javier Torres-Jiménez (J Torres-Jiménez, J Torres)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Javier Torres-Jiménez, Javier Baena Espinar, Helena Bote de Cabo, María Zurera Berjaga, Jorge Esteban-Villarrubia, Jon Zugazagoitia Fraile, Luis Paz-Ares
Targeting KRAS G12C in Non-Small-Cell Lung Cancer: Current Standards and Developments. Drugs (2024)
Javier Torres-Jiménez, Javier Baena Espinar, Helena Bote de Cabo, María Zurera Berjaga, Jorge Esteban-Villarrubia, Jon Zugazagoitia Fraile, Luis Paz-Ares
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments. Drugs (2024)
Javier Torres-Jiménez, Javier Baena Espinar, Helena Bote de Cabo, María Zurera Berjaga, Jorge Esteban-Villarrubia, Jon Zugazagoitia Fraile, Luis Paz-Ares
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments. Drugs 84 (5) (2024)
Javier Torres-Jiménez, Javier Baena Espinar, Helena Bote de Cabo, María Zurera Berjaga, Jorge Esteban-Villarrubia, Jon Zugazagoitia Fraile, Luis Paz-Ares
Targeting KRAS G12C in Non-Small-Cell Lung Cancer: Current Standards and Developments. Drugs (2024)
Javier Torres-Jiménez, Javier Baena Espinar, Helena Bote de Cabo, María Zurera Berjaga, Jorge Esteban-Villarrubia, Jon Zugazagoitia Fraile, Luis Paz-Ares
Targeting KRAS G12C in Non-Small-Cell Lung Cancer: Current Standards and Developments. Drugs 84 (5) (2024)
Javier Torres-Jiménez, Javier Baena Espinar, Helena Bote de Cabo, María Zurera Berjaga, Jorge Esteban-Villarrubia, Jon Zugazagoitia Fraile, Luis Paz-Ares
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments. Drugs (2024)
Javier Torres-Jiménez, Javier Baena Espinar, Helena Bote de Cabo, María Zurera Berjaga, Jorge Esteban-Villarrubia, Jon Zugazagoitia Fraile, Luis Paz-Ares
Targeting KRAS G12C in Non-Small-Cell Lung Cancer: Current Standards and Developments. Drugs (2024)
Jorge Esteban-Villarrubia, Javier Torres-Jiménez, Carolina Bueno-Bravo, Rebeca García-Mondaray, José Daniel Subiela, Pablo Gajate
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer. Cancers 15 (3) (2023)
María San Román-Gil, Javier Torres-Jiménez, Javier Pozas, Jorge Esteban-Villarrubia, Víctor Albarrán-Fernández, Pablo Álvarez Ballesteros, Jesús Chamorro-Pérez, Diana Rosero-Rodríguez, Inmaculada Orejana-Martín, Íñigo Martínez-Delfrade, Pablo Reguera-Puertas, Raquel Fuentes-Mateos, María Reyes Ferreiro
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma. Cancers 15 (3) (2023)
María San Román-Gil, Javier Torres-Jiménez, Javier Pozas, Jorge Esteban-Villarrubia, Víctor Albarrán-Fernández, Pablo Álvarez Ballesteros, Jesús Chamorro-Pérez, Diana Rosero-Rodríguez, Inmaculada Orejana-Martín, Íñigo Martínez-Delfrade, Pablo Reguera-Puertas, Raquel Fuentes-Mateos, María Reyes Ferreiro
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma. Cancers 15 (3) (2023)
Jorge Esteban-Villarrubia, Javier Torres-Jiménez, Carolina Bueno-Bravo, Rebeca García-Mondaray, José Daniel Subiela, Pablo Gajate
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer. Cancers 15 (3) (2023)
Javier Torres-Jiménez, Jorge Esteban, Reyes Ferreiro-Monteagudo
Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene. Cancers 14 (15) (2022)
Víctor Albarrán-Artahona, Juan-Carlos Laguna, Teresa Gorría, Javier Torres-Jiménez, Mariona Pascal, Laura Mezquita
Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy. Diagnostics (Basel, Switzerland) 12 (9) (2022)
Javier Torres-Jiménez, Víctor Albarrán Fernández, Javier Pozas, María San Román-Gil, Jorge Esteban-Villarrubia, Alfredo Carrato, Adriana Carolina Rosero Rodríguez, Enrique Grande, Teresa Alonso Gordoa, Javier Molina-Cerrillo
Novel Tyrosine Kinase Targets in Urothelial Carcinoma. International journal of molecular sciences 22 (2) (2021)
Javier Torres-Jiménez, Jorge Esteban-Villarrubia, Reyes Ferreiro-Monteagudo, Alfredo Carrato
Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist. Cancers 13 (23) (2021)
Javier Torres-Jiménez, J Esteban-Villarrubia, P García-Abellás, A Cortés-Salgado, A Soria-Rivas, P Gajate-Borau, M E Olmedo-García, E Corral-de la Fuente, Y Lage-Alfranca, A Gómez-Rueda, A Benito-Berlinches, L Gorospe-Sarasua, P Garrido-López
Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (7) (2021)
Jorge Esteban-Villarrubia, Juan José Soto Castillo, Javier Pozas, María San Román-Gil, Inmaculada Orejana-Martín, Javier Torres-Jiménez, Alfredo Carrato, Teresa Alonso Gordoa, Javier Molina-Cerrillo
Tyrosine Kinase Receptors in Oncology. International journal of molecular sciences 21 (22) (2020)
M A Vaz Salgado, Javier Torres-Jiménez, J Esteban, J A Gutiérrez, L Ley, A Carrato
Survey of treatment recommendations for elderly patients with glioblastoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (8) (2019)

Javier Torres-Jiménez.css-eqlu8i{font-size:small;padding-left:4px;} (J Torres-Jiménez, J Torres)

Publication Activity (10 Years)

Top Topics

Top Venues

Javier Torres-Jiménez (J Torres-Jiménez, J Torres)